Suboptimal cotrimoxazole prophylactic concentrations in HIV‐infected children according to the WHO guidelines

AIMS: A clinical study was conduct in HIV‐infected children to evaluate the prophylactic doses of cotrimoxazole [sulfamethoxazole (SMX) and trimethoprim (TMP)] advised by the WHO. METHODS: Children received lopinavir‐based antiretroviral therapy with cotrimoxazole prophylaxis (200 mg of SMX/40 mg of...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Br J Clin Pharmacol
Hlavní autoři: Pressiat, Claire, Mea‐Assande, Veronique, Yonaba, Caroline, Treluyer, Jean‐Marc, Dahourou, Désiré‐Lucien, Amorissani‐Folquet, Madeleine, Blanche, Stéphane, Eboua, François, Ye, Diarra, Lui, Gabrielle, Malateste, Karen, Zheng, Yi, Leroy, Valeriane, Hirt, Déborah
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2017
Témata:
Pharmacokinetics
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5698578/
https://ncbi.nlm.nih.gov/pubmed/28800382
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13397
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky